Figure 3 | Scientific Reports

Figure 3

From: Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy

Figure 3

Flowchart of patient inclusion. We enrolled the total of 308 patients who were suspected of having ovarian malignancy and underwent surgery at our institution during the period from January 2013 to December 2018. Among of them, 171 patients were diagnosed with malignant ovarian cancer. The 27 patients with HGSOC at stage III or IV according to the revised 2014 FIGO staging system who were treated with NAC-IDS including platinum-based agents were analyzed in this study.

Back to article page